BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34347352)

  • 1. A phase I clinical trial of human embryonic stem cell-derived retinal pigment epithelial cells for early-stage Stargardt macular degeneration: 5-years' follow-up.
    Li SY; Liu Y; Wang L; Wang F; Zhao TT; Li QY; Xu HW; Meng XH; Hao J; Zhou Q; Wang L; Yin ZQ
    Cell Prolif; 2021 Sep; 54(9):e13100. PubMed ID: 34347352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.
    Schwartz SD; Regillo CD; Lam BL; Eliott D; Rosenfeld PJ; Gregori NZ; Hubschman JP; Davis JL; Heilwell G; Spirn M; Maguire J; Gay R; Bateman J; Ostrick RM; Morris D; Vincent M; Anglade E; Del Priore LV; Lanza R
    Lancet; 2015 Feb; 385(9967):509-16. PubMed ID: 25458728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration.
    Mehat MS; Sundaram V; Ripamonti C; Robson AG; Smith AJ; Borooah S; Robinson M; Rosenthal AN; Innes W; Weleber RG; Lee RWJ; Crossland M; Rubin GS; Dhillon B; Steel DHW; Anglade E; Lanza RP; Ali RR; Michaelides M; Bainbridge JWB
    Ophthalmology; 2018 Nov; 125(11):1765-1775. PubMed ID: 29884405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients.
    Sung Y; Lee MJ; Choi J; Jung SY; Chong SY; Sung JH; Shim SH; Song WK
    Br J Ophthalmol; 2021 Jun; 105(6):829-837. PubMed ID: 32727729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and functionality of xeno-free human embryonic stem cell-derived retinal pigment epithelial cells on polyester substrate after transplantation in rabbits.
    Ilmarinen T; Thieltges F; Hongisto H; Juuti-Uusitalo K; Koistinen A; Kaarniranta K; Brinken R; Braun N; Holz FG; Skottman H; Stanzel BV
    Acta Ophthalmol; 2019 Aug; 97(5):e688-e699. PubMed ID: 30593729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subretinal implantation of a monolayer of human embryonic stem cell-derived retinal pigment epithelium: a feasibility and safety study in Yucatán minipigs.
    Koss MJ; Falabella P; Stefanini FR; Pfister M; Thomas BB; Kashani AH; Brant R; Zhu D; Clegg DO; Hinton DR; Humayun MS
    Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1553-1565. PubMed ID: 27335025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium.
    Ilmarinen T; Hiidenmaa H; Kööbi P; Nymark S; Sorkio A; Wang JH; Stanzel BV; Thieltges F; Alajuuma P; Oksala O; Kataja M; Uusitalo H; Skottman H
    PLoS One; 2015; 10(11):e0143669. PubMed ID: 26606532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy.
    Humayun MS; Clegg DO; Dayan MS; Kashani AH; Rahhal FM; Avery RL; Salehi-Had H; Chen S; Chan C; Palejwala N; Ingram A; Mitra D; Pennington BO; Hinman C; Faynus MA; Bailey JK; Johnson LV; Lebkowski JS
    Ophthalmology; 2024 Jun; 131(6):682-691. PubMed ID: 38160882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy.
    Petrus-Reurer S; Bartuma H; Aronsson M; Westman S; Lanner F; Kvanta A
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration.
    Lu B; Malcuit C; Wang S; Girman S; Francis P; Lemieux L; Lanza R; Lund R
    Stem Cells; 2009 Sep; 27(9):2126-35. PubMed ID: 19521979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.
    da Cruz L; Fynes K; Georgiadis O; Kerby J; Luo YH; Ahmado A; Vernon A; Daniels JT; Nommiste B; Hasan SM; Gooljar SB; Carr AF; Vugler A; Ramsden CM; Bictash M; Fenster M; Steer J; Harbinson T; Wilbrey A; Tufail A; Feng G; Whitlock M; Robson AG; Holder GE; Sagoo MS; Loudon PT; Whiting P; Coffey PJ
    Nat Biotechnol; 2018 Apr; 36(4):328-337. PubMed ID: 29553577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Preclinical Safety Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells for Macular Degeneration.
    Mazzilli JL; Snook JD; Simmons K; Domozhirov AY; Garcia CA; Wetsel RA; Zsigmond EM; Westenskow PD
    J Ocul Pharmacol Ther; 2020; 36(1):65-69. PubMed ID: 31596637
    [No Abstract]   [Full Text] [Related]  

  • 13. A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration.
    Kashani AH; Lebkowski JS; Rahhal FM; Avery RL; Salehi-Had H; Dang W; Lin CM; Mitra D; Zhu D; Thomas BB; Hikita ST; Pennington BO; Johnson LV; Clegg DO; Hinton DR; Humayun MS
    Sci Transl Med; 2018 Apr; 10(435):. PubMed ID: 29618560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem Cell-Based Therapy for Diseases of the Retinal Pigment Epithelium: From Bench to Bedside.
    Sachdeva MM; Eliott D
    Semin Ophthalmol; 2016; 31(1-2):25-9. PubMed ID: 26959126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryonic stem cell trials for macular degeneration: a preliminary report.
    Schwartz SD; Hubschman JP; Heilwell G; Franco-Cardenas V; Pan CK; Ostrick RM; Mickunas E; Gay R; Klimanskaya I; Lanza R
    Lancet; 2012 Feb; 379(9817):713-20. PubMed ID: 22281388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cell Derived Retinal Pigment Epithelium: The Role of Pigmentation as Maturation Marker and Gene Expression Profile Comparison with Human Endogenous Retinal Pigment Epithelium.
    Bennis A; Jacobs JG; Catsburg LAE; Ten Brink JB; Koster C; Schlingemann RO; van Meurs J; Gorgels TGMF; Moerland PD; Heine VM; Bergen AA
    Stem Cell Rev Rep; 2017 Oct; 13(5):659-669. PubMed ID: 28730556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of Subretinal Suspension Transplants of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in a Large-Eyed Model of Geographic Atrophy.
    Petrus-Reurer S; Bartuma H; Aronsson M; Westman S; Lanner F; André H; Kvanta A
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1314-1322. PubMed ID: 28241319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation.
    Vugler A; Carr AJ; Lawrence J; Chen LL; Burrell K; Wright A; Lundh P; Semo M; Ahmado A; Gias C; da Cruz L; Moore H; Andrews P; Walsh J; Coffey P
    Exp Neurol; 2008 Dec; 214(2):347-61. PubMed ID: 18926821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient and robust induction of retinal pigment epithelium cells by tankyrase inhibition regardless of the differentiation propensity of human induced pluripotent stem cells.
    Ito A; Ye K; Onda M; Morimoto N; Osakada F
    Biochem Biophys Res Commun; 2021 May; 552():66-72. PubMed ID: 33743349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of stem cell-derived retinal pigment epithelial cell differentiation established for clinical translation.
    Petrus-Reurer S; Lederer AR; Baqué-Vidal L; Douagi I; Pannagel B; Khven I; Aronsson M; Bartuma H; Wagner M; Wrona A; Efstathopoulos P; Jaberi E; Willenbrock H; Shimizu Y; Villaescusa JC; André H; Sundstrӧm E; Bhaduri A; Kriegstein A; Kvanta A; La Manno G; Lanner F
    Stem Cell Reports; 2022 Jun; 17(6):1458-1475. PubMed ID: 35705015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.